Bourdon David 4
4 · LifeStance Health Group, Inc. · Filed Nov 14, 2022
Insider Transaction Report
Form 4
Bourdon David
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2022-11-10$5.53/sh−77,072$426,208→ 103,760 total - Award
Common Stock
2022-11-10+180,832→ 180,832 total - Award
Stock Option (right to buy)
2022-11-10+1,250,000→ 1,250,000 totalExercise: $5.53Exp: 2032-11-10→ Common Stock (1,250,000 underlying)
Footnotes (2)
- [F1]The options were granted by the Issuer pursuant to the LifeStance Health Group, Inc. 2021 Equity Incentive Plan.
- [F2]Includes an option to purchase 416,666 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vests as to 25% on each of the first four anniversaries of the vesting commencement date, November 10, 2022. Includes an option to purchase 833,334 shares of the Issuer's common stock, subject to time- and performance-based vesting (the "Performance-Vesting Option"). The Performance-Vesting Option vests as to up to 25% on each of the first four anniversaries of the vesting commencement date, November 10, 2022. Following each anniversary of the vesting commencement date, any portion of the Performance-Vesting Option eligible to vest as of such measurement date that did not vest pursuant to the performance-based vesting criteria will be eligible to vest on a quarterly basis thereafter, subject to the same performance-based vesting criteria.